Welcome to Medications.com
Nov 13, 2007 VANCOUVER, BRITISH COLUMBIA MARKET WIRE - Genetic Engineering News (press release)
This study is a randomized, examiner-blinded, parallel design trial comparing three doses of PAC-113 to Nystatin mouthrinse. The study will enroll about 200 ...
http://www.genengnews.com/news/bn... |
Posted: Tue Nov 13 08:47:16 -0500 2007
Nystatin Topical RSS FeedFrequently Reported Side Effects of Nystatin Topical
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
